Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nature Medicine

• Publication date

  2012-12-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.2999PMID 23202296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1’s inhibitory effect on Bak

  2011cited by this paper
• Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.

  2011cited by this paper
• Restoration of antitumor immunity through selective inhibition of myeloid derived suppressor cells by anticancer therapies.

  2011cited by this paper
• Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice

  2011cited by this paper
• Microenvironment-Derived IL-1 and IL-17 Interact in the Control of Lung Metastasis

  2011cited by this paper
• Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

  2011cited by this paper
• The inflammasome: an integrated view

  2011cited by this paper
• The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment.

  2011cited by this paper
• On a Chip

  2011cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• Why not treat human cancer with interleukin-1 blockade?

  2010cited by this paper
• The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells.

  2010cited by this paper
• IL-17 Promotes Tumor Development through the Induction of Tumor Promoting Microenvironments at Tumor Sites and Myeloid-Derived Suppressor Cells

  2010cited by this paper
• 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.

  2010cited by this paper
• Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• Revisited BIA-MS combination: entire "on-a-chip" processing leading to the proteins identification at low femtomole to sub-femtomole levels.

  2009cited by this paper
• Critical regulation of early Th17 cell differentiation by interleukin-1 signaling.

  2009cited by this paper
• Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1

  2009cited by this paper
• IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway

  2009cited by this paper
• TGF-β Promotes Th17 Cell Development through Inhibition of SOCS31

  2009cited by this paper
• Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

  2009cited by this paper
• Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

  2008cited by this paper
• Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.

  2008cited by this paper
• Tumor escape mechanism governed by myeloid-derived suppressor cells.

  2008cited by this paper
• Is interleukin‐1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?

  2008cited by this paper
• Immunological aspects of cancer chemotherapy

  2008cited by this paper
• Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.

  2007cited by this paper
• Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

  2007cited by this paper
• Calreticulin exposure dictates the immunogenicity of cancer cell death

  2007cited by this paper
• Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production

  2007cited by this paper
• Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.

  2007cited by this paper
• Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response1

  2007cited by this paper
• The inflammasome: a danger sensing complex triggering innate immunity.

  2007cited by this paper
• Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.

  2007cited by this paper
• Inflammation and cancer: a double-edged sword.

  2007cited by this paper
• Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells

  2007cited by this paper
• Cellular pharmacology of gemcitabine.

  2006cited by this paper
• Smoldering and polarized inflammation in the initiation and promotion of malignant disease.

  2005cited by this paper
• Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity

  2005cited by this paper
• Effector memory T cells, early metastasis, and survival in colorectal cancer.

  2005cited by this paper
• IKK Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer

  2004cited by this paper
• NALPs: a novel protein family involved in inflammation

  2003cited by this paper
• Interleukin-17 promotes angiogenesis and tumor growth.

  2003cited by this paper
• Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

  2003cited by this paper
• 5-Fluorouracil: mechanisms of action and clinical strategies

  2003cited by this paper
• Double Edged Sword

  2002cited by this paper
• CA074 methyl ester: a proinhibitor for intracellular cathepsin B.

  1992cited by this paper
• Immunological Aspects of Cancer Chemotherapy

  1980cited by this paper
• An integrated view.

  1973cited by this paper

• A Spatially Ordered Three-Input Logic Gate for Highly Specific and Sensitive Breast Tumor Imaging.

  2026cites this paper
• High-cholesterol-load-triggered pyroptosis of gingival fibroblasts promotes periodontitis.

  2026cites this paper
• Deficiency of lysosomal TMEM175 in myeloid macrophages exerts anti-tumor immunity via inflammasome and cross-presentation pathway.

  2026cites this paper
• Inhibition of Cathepsin B protects against vandetanib-induced hepato-cardiotoxicity by restoring lysosomal damage

  2026cites this paper
• Targeting Cathepsin B-mediated pyroptosis in fibroblasts alleviate ultraviolet-induced skin inflammation and injury

  2025cites this paper
• Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance

  2025cites this paper
• Impact of tumor metabolism on tumor progression and therapy Cathepsins: emerging targets in the tumor ecosystem to overcome cancers.

  2025cites this paper
• Inflammasomes and Cardiovascular Disease: Linking Inflammation to Cardiovascular Pathophysiology

  2025cites this paper
• ESCRT III-mediated lysosomal repair improve renal tubular cell injury in cisplatin-induced AKI

  2025cites this paper
• The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs

  2025cites this paper
• Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial

  2025cites this paper
• Extracellular Cathepsin B Is a Potential Therapeutic Target in Hepatocellular Carcinoma

  2025cites this paper
• The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer

  2025cites this paper
• Conventional Chemotherapy and Inflammation: What Is the Role of the Inflammasome in the Tumor Microenvironment?

  2025cites this paper
• Cancer Immunotherapy in Combination with Radiotherapy and/or Chemotherapy: Mechanisms and Clinical Therapy

  2025cites this paper
• The role of TLR-4 in chemoresistance of cancer

  2025cites this paper
• Multifaceted role of myeloid-derived suppressor cells in colorectal cancer.

  2025cites this paper
• Transcriptomic Signatures of Monocyte‐Derived Macrophages Associate With Androgen Receptor Pathway Inhibitor Progression in Prostate Cancer

  2025cites this paper
• MSC-derived exosomes alleviate oxidative stress-induced lysosomal membrane permeabilization damage in degenerated nucleus pulposus cells via promoting m6A demethylation of Nrf2.

  2025cites this paper
• Multi-omics genetic study revealing ferroptosis regulator CTSB driving prostate cancer progression by modulating the immune microenvironment

  2025cites this paper
• Microglial activation and lysosomal dysfunction in hemorrhagic stroke

  2025cites this paper
• NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy

  2025cites this paper
• The Role of the Tumor Microenvironment (TME) in Advancing Cancer Therapies: Immune System Interactions, Tumor-Infiltrating Lymphocytes (TILs), and the Role of Exosomes and Inflammasomes

  2025cites this paper
• Inflammation in cancer: therapeutic opportunities from new insights

  2025cites this paper
• Effects of albumin-bound paclitaxel combined with Sophora subprostrate polysaccharide on inflammatory factors and immune function in breast cancer rats

  2025cites this paper
• Cytotoxic chemotherapy in a 3D microfluidic device induces dendritic cell recruitment and trogocytosis of cancer cells.

  2025cites this paper
• Lysosome heterogeneity and diversity mapped through its distinct cellular functions

  2025cites this paper
• Interleukin-1β and cancer immune response.

  2025cites this paper
• Macrophage NLRP3 activation and IL-1β release drive osimertinib-induced antitumor immunity

  2025cites this paper
• NLRP3 inflammasome expression affects immune cell infiltration and clinical prognosis in Helicobacter pylori infection‑associated gastric cancer

  2025cites this paper
• FZD6 promotes 5-fluorouracil resistance through inhibiting pyroptosis in colorectal cancer.

  2025cites this paper
• Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies

  2025cites this paper
• The efficacy and safety of chemoimmunotherapy in patients with MSI-L/MSS/pMMR status metastatic colorectal cancer: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer.

  2025cites this paper
• Chemotherapy-induced CA-repeat DNA fragments in breast cancer trigger antitumor immune responses

  2025cites this paper
• An Intracellular Magnetic Micromotor Drives Spatiotemporal Mechano‐Immunotherapy

  2025cites this paper
• Dual roles of innate immune cells and cytokines in shaping the breast cancer microenvironment

  2025cites this paper
• Immune cell metabolism in cancer drug resistance: Advances in target discovery and clinical translation.

  2025cites this paper
• Cysteine protease cathepsin B promotes high population density-induced mutagenesis, driving genome evolution and competitive growth in response to the crowding stress

  2025cites this paper
• Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives

  2025cites this paper
• Exploring therapeutic and diagnostic potential of cysteine cathepsin as targets for cancer therapy with nanomedicine.

  2025cites this paper
• Redirecting the Peptide Cleavage Causes Protease Inactivation

  2025cites this paper
• Organelles and cancer cell pyroptosis: overview and perspectives

  2025cites this paper
• Responsive Photosensitizer Precursors Reverse Drug-Induced Secondary Immunosuppression.

  2025cites this paper
• NLRs in Tumor Chemotherapy Resistance: A Double-Edged Sword.

  2025cites this paper
• Quantitative spatial profiling of PD-1/PD-L1 and TIGIT/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma.

  2025cites this paper
• The SGLT2 inhibitor dapagliflozin suppresses endothelial cell pyroptosis mediated by the NF-κB/NLRP3 pathway through downregulation of CTSB.

  2025cites this paper
• Whole transcriptome sequencing indicated the Anti-tumor immunity of NLRP3 in breast cancer.

  2024cites this paper
• IL-1β mediates Candida tropicalis-induced immunosuppressive function of MDSCs to foster colorectal cancer

  2024cites this paper
• Regulation of NLRP3 inflammasome and Caspase-3/4/11 by 2',4'-dihydroxychalcone contributes to anti-colorectal cancer.

  2024cites this paper
• Balanced regulation of ROS production and inflammasome activation in preventing early development of colorectal cancer

  2024cites this paper
• The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases

  2024cites this paper
• Underlying Mechanism of Lysosomal Membrane Permeabilization in CNS Injury: A Literature Review

  2024cites this paper
• Phase I/II study of trifluridine/tipiracil plus XB2001 versus trifluridine/tipiracil in metastatic colorectal cancer.

  2024cites this paper
• The Role of Inflammasome-Associated Innate Immune Receptors in Cancer

  2024influential citation
• The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?

  2024cites this paper
• Single-cell data revealed the function of natural killer cells and macrophage cells in chemotherapy tolerance in acute myeloid leukemia

  2024cites this paper
• Dysregulation of systemic immunity in colorectal cancer and its clinical applications as biomarkers and therapeutics.

  2024cites this paper
• Dysregulation of systemic immunity and its clinical application in gastric cancer

  2024cites this paper
• IDH2 regulates macrophage polarization and tumorigenesis by modulating mitochondrial metabolism in macrophages

  2024cites this paper
• Photothermal induction of pyroptosis in malignant glioma spheroids using (16-mercaptohexadecyl)trimethylammonium bromide-modified cationic gold nanorods.

  2024cites this paper
• Growth hormone – releasing hormone in the context of inflammation and redox biology

  2024cites this paper
• Targeted nanomedicine for reprogramming the tumor innate immune system: From bench to bedside.

  2024cites this paper
• Specific depletion of myeloid-derived suppressor cells by the chemotherapeutic agent 5-Fluorouracil enhances protective immune response in Paracoccidioidomycosis.

  2024cites this paper
• Dual Role of Lysosome in Cancer Development and Progression.

  2024cites this paper
• The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer

  2024cites this paper
• In situ chemoimmunotherapy hydrogel elicits immunogenic cell death and evokes efficient antitumor immune response

  2024cites this paper
• Inflammasomes Are Influenced by Epigenetic and Autophagy Mechanisms in Colorectal Cancer Signaling

  2024cites this paper
• Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders

  2024cites this paper
• Pharmacological approaches for targeting lysosomes to induce ferroptotic cell death in cancer.

  2024cites this paper
• Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment

  2024cites this paper
• Arresting the G2/M phase empowers synergy in magnetic nanomanipulator-based cancer mechanotherapy and chemotherapy.

  2024cites this paper
• Cinnamaldehyde inhibits the NLRP3 inflammasome by preserving mitochondrial integrity and augmenting autophagy in Shigella sonnei-infected macrophages

  2024cites this paper
• Cryptotanshinone Inhibits Bladder Cancer Cell Malignant Progression in a Lipopolysaccharide-Induced Inflammatory Microenvironment through NLRP3 Inhibition

  2024cites this paper
• Thermal Proteome Profiling Strategy Identifies CNPY3 as a Cellular Target of Gambogic Acid for Inducing Prostate Cancer Pyroptosis.

  2024cites this paper
• Targeting inflammation as cancer therapy

  2024cites this paper
• Polyvalent DNA-based bioorthogonal nano-agonist for robust chemo-immunotherapy

  2024cites this paper
• Emerging role of immunogenic cell death in cancer immunotherapy

  2024cites this paper
• Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors

  2024cites this paper
• Chemical conjugation mitigates immunotoxicity of chemotherapy via reducing receptor-mediated drug leakage from lipid nanoparticles

  2024cites this paper
• Disulfide bonds as a molecular switch of enzyme-activatable anticancer drug precise release for fluorescence imaging and enhancing tumor therapy.

  2024cites this paper
• Using immunogenic cell death to improve anticancer efficacy of immune checkpoint inhibitors: From basic science to clinical application

  2023cites this paper
• Abnormal generation of IL-17A represses tumor infiltration of stem-like exhausted CD8+ T cells to demote the antitumor immunity

  2023cites this paper
• Dapagli ozin Attenuates NLRP3/Caspase-1 Signaling Pathway-Mediated Pyroptosis of Vascular Smooth Muscle Cells by Down-regulating CTSB

  2023cites this paper
• First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial

  2023cites this paper
• Arachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts

  2023cites this paper
• The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies

  2023cites this paper
• MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target

  2023cites this paper
• Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential

  2023cites this paper
• Pyroptosis: A road to next-generation cancer immunotherapy.

  2023cites this paper
• Targeting innate immune pathways for cancer immunotherapy.

  2023cites this paper
• Lung inflammation perturbation by engineered nanoparticles

  2023cites this paper
• Eat, prey, love: Pathogen-mediated subversion of lysosomal biology.

  2023cites this paper
• Cathepsin B S-nitrosylation promotes ADAR1-mediated editing of its own mRNA transcript via an ADD1/MATR3 regulatory axis

  2023cites this paper
• Transforming cancer cells for long-term living with cancer: An inspiring new approach.

  2023cites this paper
• Recombinant Treponema pallidum protein Tp47 promoted the phagocytosis of macrophages by activating NLRP3 inflammasome induced by PKM2‐dependent glycolysis

  2023cites this paper
• Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers

  2023cites this paper
• The role of microglial LRRK2 in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction

  2023cites this paper
• Divergent functions of NLRP3 inflammasomes in cancer: a review

  2023cites this paper
• The role of NLRP3 inflammasome-mediated pyroptosis in ischemic stroke and the intervention of traditional Chinese medicine

  2023cites this paper